Evidence map›Paper›PMID 37170006›Full record

ArticleJournal of cancer survivorship : research and practice2024

Positive and negative survivor-specific psychosocial consequences of childhood cancer: the DCCSS-LATER 2 psycho-oncology study.

Anne Maas, Heleen Maurice-Stam, Alied M van der Aa-van Delden, Elvira C van Dalen, Eline van Dulmen-den Broeder, Wim J E Tissing, Jacqueline J Loonen, Helena J H van der Pal, Andrica C H de Vries, Marry M van den Heuvel-Eibrink and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 3 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Anne MaasPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. a.maas-9@prinsesmaximacentrum.nl.
Heleen Maurice-StamPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Alied M van der Aa-van DeldenPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Elvira C van DalenPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Eline van Dulmen-den BroederAmsterdam UMC/Location VUmc, Amsterdam, The Netherlands.
Wim J E TissingPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Jacqueline J LoonenRadboud University Medical Center, Nijmegen, The Netherlands.
Helena J H van der PalPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Andrica C H de VriesPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Marry M van den Heuvel-EibrinkPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Geert O JanssensPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Cécile RonckersPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Sebastian NeggersPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Dorine BrestersPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Marloes LouwerensLeiden University Medical Center, Leiden, The Netherlands.
Birgitta A B VersluysPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Margriet van der Heiden-van der LooPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Leontien C M KremerPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Marloes van GorpPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Martha A GrootenhuisPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Dutch LATER study group
Princess Máxima Center · NLAmsterdam University Medical Centers · NLErasmus MC - Sophia Children’s Hospital · NLJohannes Gutenberg University Mainz · DELeiden University Medical Center · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NL

Funding

Stichting Kinderen Kankervrij 361 & 171
6 · The paper itself

Abstract

purposeNumerous studies investigated generic psychosocial outcomes in survivors of childhood cancer (CCS). The present study aimed to describe survivor-specific psychosocial consequences in CCS, and to identify socio-demographic and medical associated factors.

methodsCCS from the Dutch Childhood Cancer Survivor Study (DCCSS)-LATER cohort (diagnosed 1963-2001) part 2 (age ≥ 18 years, diagnosed < 18 years, ≥ 5 years since diagnosis) completed the Benefit & Burden Scale (BBSC) and the Impact of Cancer-Childhood Cancer (IOC-CS). Items were scored on a 5-point Likert scale (range 1-5). We examined outcomes with descriptive statistics, and socio-demographic and medical associated factors with regression analyses, corrected for multiple testing (p < 0.004).

resultsCCS, N = 1713, age mean (M) 36 years, 49% female, ≥ 15 years since diagnosis, participated. On average, CCS reported 'somewhat' Benefit (M = 2.9), and 'not at all' to 'a little' Burden (M = 1.5) of childhood cancer. Average scores on IOC-CS' positive impact scales ranged from 2.5 (Personal Growth) to 4.1 (Socializing), and on the negative impact scales from 1.4 (Financial Problems) to 2.4 (Thinking/Memory). Apart from cognitive problems, CCS reported challenges as worries about relationship status, fertility, and how cancer had affected siblings. Female sex was associated with more Personal Growth, and more negative impact. CCS more highly educated, partnered, and employed had higher positive and lower negative impact. CCS older at diagnosis reported more positive impact. CNS tumor survivors and those who had head/cranium radiotherapy had higher negative impact. CNS tumor survivors reported less positive impact. CONCLUSION AND IMPLICATIONS: The majority of CCS reported positive impact of cancer while most CCS reported little negative impact. While this may indicate resiliency in most CCS, health care providers should be aware that they can also experience survivor-specific challenges that warrant monitoring/screening, information provision and psychosocial support.

Indexed as

Cancer SurvivorsNeoplasmsAdolescentAdultChildChild, PreschoolCohort StudiesFemaleHumansMaleMiddle AgedPsycho-OncologyQuality of LifeSurveys and QuestionnairesYoung AdultChildhood cancer survivorsImpact of cancerLong-term survivorshipPsychosocialQuality of life

Identifiers

PMID37170006
PMCPMC11424676
OpenAlexW4376225449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.